Initially criticized for his ties to the pharmaceutical industry, Gottlieb, a former venture capitalist, became known for his aggressive regulatory stance in the Trump administration.
Initially criticized for his ties to the pharmaceutical industry, Gottlieb, a former venture capitalist, became known for his aggressive regulatory stance in the Trump administration.